KB Financial Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
KB Financial Partners's EXAS Position: Q3 2023 in Review
KB Financial Partners increased its Exact Sciences (EXAS) stake by 15% in Q3 2023, buying an estimated $4.5K and bringing the position to 397 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #325.
KB Financial Partners first reported a position in EXAS in Q1 2021 and has held it in 3 quarters since. The position peaked at $32K in Q2 2023. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.
- KB Financial Partners held 397 shares of Exact Sciences worth $27K as of Q3 2023.
- KB Financial Partners bought 53 Exact Sciences shares in Q3 2023, an estimated $4.5K.
- Exact Sciences made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #325 holding.
- KB Financial Partners first reported a position in Exact Sciences in Q1 2021 and has held it in 3 quarters since.
- KB Financial Partners's Exact Sciences position peaked at $32K in Q2 2023.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.
Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.